{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:09:43Z","timestamp":1794622183756,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI17C1438"],"award-info":[{"award-number":["HI17C1438"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016R1A5A2945889"],"award-info":[{"award-number":["2016R1A5A2945889"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1A2B2010237"],"award-info":[{"award-number":["2017R1A2B2010237"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1D1A1B07041560"],"award-info":[{"award-number":["2018R1D1A1B07041560"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pathogenic variants in the human <jats:italic>SCN5A<\/jats:italic> gene encoding the <jats:italic>a<\/jats:italic>-subunit of the principle Na<jats:sup>+<\/jats:sup> channel (Nav1.5) are associated with long QT syndrome (LQTS) 3. LQT3 patients display variable responses to Na<jats:sup>+<\/jats:sup> channel blockers demanding for the development of variant-specific therapeutic strategies. Here we performed a combined electrophysiological analysis with in silico simulation of variant channel to elucidate mechanisms of therapeutic responsiveness. We identified a novel <jats:italic>SCN5A<\/jats:italic> variant (A1656D) in a LQTS patient with a distinct response to mexiletine resulting in suppression of non-sustained ventricular tachycardia and manifestation of premature atrial contraction. Patch clamp analysis revealed that A1656D variant exerted gain-of-function effects including hyperpolarizing shift of the voltage-dependence of activation, depolarizing shift in the voltage-dependence of inactivation, and slowing of fast inactivation. Among ranolazine, flecainide, and mexiletine, only mexiletine restored inactivation kinetics of A1656D currents. In silico simulation to assess the effect of A1656D variant on ventricular cardiac cell excitation predicted a prolonged action potential which is consistent with the prolonged QT and non-sustained ventricular tachycardia of the patient. It also predicted that only mexiletine suppressed the prolonged action potential of human ventricular myocytes expressing A1656D. These data elucidate the underlying mechanism of the distinct response to mexiletine in this patient.<\/jats:p>","DOI":"10.1038\/s41598-019-49450-0","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T10:04:12Z","timestamp":1568109852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Characterization of a novel LQT3 variant with a selective efficacy of mexiletine treatment"],"prefix":"10.1038","volume":"9","author":[{"given":"Hyun-Ji","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6078-7453","authenticated-orcid":false,"given":"Bok-Geon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Seok","family":"Ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Boum","family":"Youm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Sun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,10]]},"reference":[{"key":"49450_CR1","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/0092-8674(91)90374-8","volume":"67","author":"LJ Pt\u00e1\u010dek","year":"1991","unstructured":"Pt\u00e1\u010dek, L. J. et al. Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 67, 1021\u20131027 (1991).","journal-title":"Cell"},{"key":"49450_CR2","first-page":"569","volume":"4","author":"AAM Wilde","year":"2018","unstructured":"Wilde, A. A. M. & Amin, A. S. Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy. JACC: Clinical Electrophysiology 4, 569\u2013579 (2018).","journal-title":"JACC: Clinical Electrophysiology"},{"key":"49450_CR3","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/j.bbamcr.2016.02.014","volume":"1863","author":"E Zaklyazminskaya","year":"2016","unstructured":"Zaklyazminskaya, E. & Dzemeshkevich, S. The role of mutations in the SCN5A gene in cardiomyopathies. Biochimica et Biophysica Acta - Molecular Cell Research 1863, 1799\u20131805 (2016).","journal-title":"Biochimica et Biophysica Acta - Molecular Cell Research"},{"key":"49450_CR4","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1172\/JCI25537","volume":"115","author":"AJ Moss","year":"2005","unstructured":"Moss, A. J. & Kass, R. S. Long QT syndrome: from channels to cardiac arrhythmias. Journal of Clinical Investigation 115, 2018\u20132024 (2005).","journal-title":"Journal of Clinical Investigation"},{"key":"49450_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1152\/physrev.00008.2016","volume":"97","author":"MS Bohnen","year":"2016","unstructured":"Bohnen, M. S. et al. Molecular Pathophysiology of Congenital Long QT Syndrome. Physiological Reviews 97, 89\u2013134 (2016).","journal-title":"Physiological Reviews"},{"key":"49450_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.tcm.2018.03.003","volume":"7","author":"JR Giudicessi","year":"2018","unstructured":"Giudicessi, J. R. et al. The genetic architecture of long QT syndrome: A critical reappraisal. Trends in cardiovascular medicine 7, 453\u2013464 (2018).","journal-title":"Trends in cardiovascular medicine"},{"key":"49450_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/jhg.2015.74","volume":"61","author":"Y Nakano","year":"2015","unstructured":"Nakano, Y. & Shimizu, W. Genetics of long-QT syndrome. Journal Of Human Genetics 61, 51 (2015).","journal-title":"Journal Of Human Genetics"},{"key":"49450_CR8","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMoa022147","volume":"348","author":"SG Priori","year":"2003","unstructured":"Priori, S. G. et al. Risk Stratification in the Long-QT Syndrome. New England Journal of Medicine 348, 1866\u20131874 (2003).","journal-title":"New England Journal of Medicine"},{"key":"49450_CR9","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.amjcard.2012.01.361","volume":"109","author":"AD Blaufox","year":"2018","unstructured":"Blaufox, A. D. et al. Congenital Long QT 3 in the Pediatric Population. American Journal of Cardiology 109, 1459\u20131465 (2018).","journal-title":"American Journal of Cardiology"},{"key":"49450_CR10","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1001\/jama.292.11.1341","volume":"292","author":"P SG","year":"2004","unstructured":"SG, P., Napolitano, C. & PJ, S. Association of long qt syndrome loci and cardiac events among patients treated with \u03b2-blockers. JAMA 292, 1341\u20131344 (2004).","journal-title":"JAMA"},{"key":"49450_CR11","doi-asserted-by":"publisher","first-page":"89 LP","DOI":"10.1161\/01.CIR.103.1.89","volume":"103","author":"PJ Schwartz","year":"2001","unstructured":"Schwartz, P. J. et al. Genotype-Phenotype Correlation in the Long-QT Syndrome. Circulation 103, 89 LP\u201395 (2001).","journal-title":"Circulation"},{"key":"49450_CR12","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1056\/NEJM199810013391404","volume":"339","author":"W Zareba","year":"1998","unstructured":"Zareba, W. et al. Influence of the Genotype on the Clinical Course of the Long-QT Syndrome. New England Journal of Medicine 339, 960\u2013965 (1998).","journal-title":"New England Journal of Medicine"},{"key":"49450_CR13","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","volume":"67","author":"A Mazzanti","year":"2016","unstructured":"Mazzanti, A. et al. Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3. Journal of the American College of Cardiology 67, 1053\u20131058 (2016).","journal-title":"Journal of the American College of Cardiology"},{"key":"49450_CR14","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1161\/CIRCULATIONAHA.107.707877","volume":"116","author":"Y Ruan","year":"2007","unstructured":"Ruan, Y., Liu, N., Bloise, R., Napolitano, C. & Priori, S. G. Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients. Circulation 116, 1137\u20131144 (2007).","journal-title":"Circulation"},{"key":"49450_CR15","unstructured":"Riaz, N., Wolden, S. L., Gelblum, D. Y. & Eric, J. HHS Public Access. 118, 6072\u20136078 (2016)."},{"key":"49450_CR16","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.hrthm.2017.07.026","volume":"14","author":"M Paci","year":"2017","unstructured":"Paci, M., Passini, E., Severi, S., Hyttinen, J. & Rodriguez, B. Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to antiarrhythmic pharmacologic therapy: An in silico approach. Heart Rhythm 14, 1704\u20131712 (2017).","journal-title":"Heart Rhythm"},{"key":"49450_CR17","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1073\/pnas.1218154110","volume":"110","author":"M Deo","year":"2013","unstructured":"Deo, M. et al. KCNJ2 mutation in short QT syndrome 3 results in atrial fibrillation and ventricular proarrhythmia. Proceedings of the National Academy of Sciences 110, 4291\u20134296 (2013).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"49450_CR18","doi-asserted-by":"publisher","first-page":"13200 LP","DOI":"10.1073\/pnas.93.23.13200","volume":"93","author":"DW Wang","year":"1996","unstructured":"Wang, D. W., Yazawa, K., George, A. L. & Bennett, P. B. Characterization of human cardiac Na+ channel mutations in the congenital long QT\u2009syndrome. Proceedings of the National Academy of Sciences 93, 13200 LP\u201313205 (1996).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"49450_CR19","doi-asserted-by":"publisher","first-page":"3381 LP","DOI":"10.1161\/01.CIR.92.12.3381","volume":"92","author":"PJ Schwartz","year":"1995","unstructured":"Schwartz, P. J. et al. Long QT Syndrome Patients With Mutations of the SCN5A and HERG Genes Have Differential Responses to Na+ Channel Blockade and to Increases in Heart Rate. Circulation 92, 3381 LP\u20133386 (1995).","journal-title":"Circulation"},{"issue":"14","key":"49450_CR20","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1161\/01.CIR.101.14.1698","volume":"101","author":"J. Benhorin","year":"2000","unstructured":"Benhorin, J. et al. Effects of Flecainide in Patients With New SCN5A Mutation. Circulation 101, 1698 LP\u20131706 (2000).","journal-title":"Circulation"},{"key":"49450_CR21","doi-asserted-by":"publisher","first-page":"H1573","DOI":"10.1152\/ajpheart.00794.2003","volume":"286","author":"KH ten Tusscher","year":"2003","unstructured":"ten Tusscher, K. H., Noble, D., Noble, P. J. & Panfilov, A. V. A model for human ventricular tissue. Am J Physiol Heart Circ Physiol 286, H1573\u201389 (2003).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"49450_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00424-013-1337-6","volume":"466","author":"CS Ki","year":"2014","unstructured":"Ki, C. S. et al. A KCNQ1 mutation causes age-dependant bradycardia and persistent atrial fibrillation. Pflugers Archiv European Journal of Physiology 466, 529\u2013540 (2014).","journal-title":"Pflugers Archiv European Journal of Physiology"},{"key":"49450_CR23","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/376683a0","volume":"376","author":"PB Bennett","year":"1995","unstructured":"Bennett, P. B., Yazawa, K., Makita, N. & George, A. L. Jr. Molecular mechanism for an inherited cardiac arrhythmia. Nature 376, 683 (1995).","journal-title":"Nature"},{"key":"49450_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pbiomolbio.2008.10.005","volume":"98","author":"T Zimmer","year":"2008","unstructured":"Zimmer, T. & Surber, R. SCN5A channelopathies \u2013 An update on mutations and mechanisms. Progress in Biophysics and Molecular Biology 98, 120\u2013136 (2008).","journal-title":"Progress in Biophysics and Molecular Biology"},{"key":"49450_CR25","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.hrthm.2009.05.021","volume":"6","author":"JD Kapplinger","year":"2005","unstructured":"Kapplinger, J. D. et al. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION(\u00ae) long QT syndrome genetic test. Heart rhythm: the official journal of the Heart Rhythm Society 6, 1297\u20131303 (2005).","journal-title":"Heart rhythm: the official journal of the Heart Rhythm Society"},{"key":"49450_CR26","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1001\/jama.294.23.2975","volume":"294","author":"C Napolitano","year":"2005","unstructured":"Napolitano, C., SG, P. & PJ, S. Genetic testing in the long qt syndrome: Development and validation of an efficient approach to genotyping in clinical practice. JAMA 294, 2975\u20132980 (2005).","journal-title":"JAMA"},{"key":"49450_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.hrthm.2005.01.020","volume":"2","author":"DJ Tester","year":"2005","unstructured":"Tester, D. J., Will, M. L., Haglund, C. M. & Ackerman, M. J. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm 2, 507\u2013517 (2005).","journal-title":"Heart Rhythm"},{"key":"49450_CR28","doi-asserted-by":"publisher","first-page":"8846","DOI":"10.1074\/jbc.M806871200","volume":"284","author":"L Tang","year":"2009","unstructured":"Tang, L., Kallen, R. G. & Horn, R. Role of an S4-S5 linker in sodium channel inactivation probed by mutagenesis and a peptide blocker. Journal of Biological Chemistry 284, 8846\u20138854 (2009).","journal-title":"Journal of Biological Chemistry"},{"key":"49450_CR29","doi-asserted-by":"publisher","first-page":"10910","DOI":"10.1073\/pnas.89.22.10910","volume":"89","author":"JW West","year":"1992","unstructured":"West, J. W. et al. A cluster of hydrophobic amino acid residues required for fast Na(+)-channel inactivation. Proceedings of the National Academy of Sciences of the United States of America 89, 10910\u201310914 (1992).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"49450_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1085\/jgp.108.2.89","volume":"108","author":"L Tang","year":"1996","unstructured":"Tang, L., Kallen, R. G. & Horn, R. Role of an S4-S5 linker in sodium channel inactivation probed by mutagenesis and a peptide blocker. The Journal of General Physiology 108, 89\u2013104 (1996).","journal-title":"The Journal of General Physiology"},{"key":"49450_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1085\/jgp.111.5.639","volume":"111","author":"L Tang","year":"1998","unstructured":"Tang, L., Chehab, N., Wieland, S. J. & Kallen, R. G. Glutamine substitution at alanine1649 in the S4\u2013S5 cytoplasmic loop of domain 4 removes the voltage sensitivity of fast inactivation in the human heart sodium channel. The Journal of general physiology 111, 639\u201352 (1998).","journal-title":"The Journal of general physiology"},{"key":"49450_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/eupace\/7.Supplement_1.77-b","volume":"7","author":"ADJ Ten Harkel","year":"2005","unstructured":"Ten Harkel, A. D. J. et al. Efficacy of an implantable cardioverter-defibrillator in a neonate with LQT3 associated arrhythmias. EP Europace 7, 77\u201384 (2005).","journal-title":"EP Europace"},{"key":"49450_CR33","doi-asserted-by":"publisher","first-page":"13 LP","DOI":"10.1136\/heart.90.1.13","volume":"90","author":"E Schulze-Bahr","year":"2004","unstructured":"Schulze-Bahr, E. et al. Long QT syndrome and life threatening arrhythmia in a newborn: molecular diagnosis and treatment response. Heart 90, 13 LP\u201316 (2004).","journal-title":"Heart"},{"key":"49450_CR34","doi-asserted-by":"publisher","first-page":"e205 LP","DOI":"10.1161\/01.CIR.0000128874.43908.CA","volume":"109","author":"H-G Kehl","year":"2004","unstructured":"Kehl, H.-G. et al. Life-Threatening Neonatal Arrhythmia. Circulation 109, e205 LP\u2013e206 (2004).","journal-title":"Circulation"},{"key":"49450_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00246-002-0169-5","volume":"24","author":"M Miura","year":"2003","unstructured":"Miura, M., Yamagishi, H., Morikawa, Y. & Matsuoka, R. Congenital long QT syndrome and 2:1 atrioventricular block with a mutation of the SCN5A gene. Pediatric Cardiology 24, 70\u201372 (2003).","journal-title":"Pediatric Cardiology"},{"key":"49450_CR36","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1124\/mol.118.114025","volume":"95","author":"H Nakagawa","year":"2019","unstructured":"Nakagawa, H., Munakata, T. & Sunami, A. Mexiletine Block of Voltage-Gated Sodium Channels: Isoform- and State-Dependent Drug\u2013Pore Interactions. Molecular Pharmacology 95, 236\u2013244 (2019).","journal-title":"Molecular Pharmacology"},{"key":"49450_CR37","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1073\/pnas.1817446116","volume":"116","author":"PT Nguyen","year":"2019","unstructured":"Nguyen, P. T., DeMarco, K. R., Vorobyov, I., Clancy, C. E. & Yarov-Yarovoy, V. Structural basis for antiarrhythmic drug interactions with the human cardiac sodium channel. Proceedings of the National Academy of Sciences 116, 2945\u20132954 (2019).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"49450_CR38","doi-asserted-by":"publisher","first-page":"H288","DOI":"10.1152\/ajpheart.00539.2010","volume":"300","author":"H Huang","year":"2010","unstructured":"Huang, H., Priori, S. G., Napolitano, C., O\u2019Leary, M. E. & Chahine, M. Y1767C, a novel SCN5A mutation, induces a persistent Na+ current and potentiates ranolazine inhibition of Na v 1.5 channels. American Journal of Physiology-Heart and Circulatory Physiology 300, H288\u2013H299 (2010).","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49450-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49450-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49450-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T13:20:09Z","timestamp":1671283209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49450-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,10]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["49450"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-49450-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,10]]},"assertion":[{"value":"15 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12997"}}